超声检查在卵巢浆液性腺癌、黏液性囊腺癌中的鉴别诊断价值

doi:10.3969/j.issn.1671-7171.2017.12.006

Abstract
Figure/Table
References
Related Citation (15)

[1] Luo T, Sun J, Zhu S,et al. Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts[J].Cancer Lett,2017,24(6):1-11.
[2] 朱学平. 卵巢癌患者CA125检测联合彩色多普勒超声检查的意义[J].中国妇幼保健,2016,31(9):1984-1986.
[3] 胥琳璟,刘国江,欧丽红,等. 卵巢癌患者经阴道彩色多普勒血流特征分析及对肿瘤恶性程度的评估价值[J].海南医学院学报,2016,22(5):503-505.
[4] 黄旴宁,刘艳婷,吴少芬. 彩色多普勒超声评分系统在卵巢良恶性肿块鉴别诊断中的应用与评价[J].中国实验诊断学,2014,18(9):1516-1518.
[5] Exacoustos C, Zupi E, Piccione E. Ultrasound imaging for ovarian and deep infiltrating endometriosis [J].Semin Reprod Med,2017,35(1):5-24.
[6] Moro F, Baima Poma C, Zannoni GF. Imaging in gynecological disease: clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors [J].Ultrasound Obstet Gynecol,2017,22(5):56-58.
[7] 张勤波. 经阴道超声检查在卵巢癌筛查中的应用进展[J].内科,2014,9(4):474-476.
[8] 樊友彬. 经阴道彩色多普勒超声测定血流速度、阻力指数对卵巢癌新辅助化疗效果的评估价值[J].海南医学院学报,2016,22(10):1012-1015.
[9] 费蕾,杨波,刘杰. 彩色多普勒超声联合血清附睾蛋白4与糖类抗原125检测对卵巢癌诊断价值的初步探讨[J].现代医学,2015,51(2):183-186.
[10] 王文娟,谢燕,刘超,等. 二维及彩色多普勒超声联合血清肿瘤标志物对卵巢癌的诊断价值[J].海南医学院学报,2015,21(12):1707-1709.
[11] 梁海丽. 经阴道彩色多普勒超声诊断卵巢癌准确性探讨[J].医药论坛杂志,2014,35(7):130-131.
[12] Baghbani F, Moztarzadeh F. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets[J].Colloids Surf B Biointerfaces,2017,23(5):132-140.
[13] 何秀英,孟海华. 彩色多普勒超声与CA125联合应用对高原藏族卵巢癌的诊断价值[J].高原医学杂志,2013,22( 2):57-59.
[14] 赖祝琴,吴宏,杨振宇,等. 超声造影联合肿瘤标志物筛查早期卵巢癌的研究[J].泰山医学院学报,2016,37(6):620-622.
(本文编辑:邓丽萍) [收稿日期] 2017-03-07